新型药物时代多发性骨髓瘤缓解动力学的影响
该研究基于626例新诊断多发性骨髓瘤患者的前瞻性非随机临床试验(BDH 2008/02),评估缓解动力学与结局的关系。研究发现缓解深度与更优结局相关,但早期缓解者(TBR≤3个月)生存显著更差;缓慢持续缓解(「U型谷」模式)结局最优,而快速短暂缓解(「过山车」模式)结局最差(中位总生存126 vs 30个月)。
要点
- 缓解深度与更优结局相关,但早期缓解者生存反而更差
- 快速完全缓解者生存不优于逐渐部分缓解者
- 缓慢持续缓解(U型谷)预后最优,快速短暂缓解(过山车)最差
核心结论
- 缓慢逐渐缓解是多发性骨髓瘤的有利预后因素。
- 除缓解深度外,缓解动力学模式是简单而有力的生存预测因素,即使在新型药物时代亦然。
研究设计与样本
- 前瞻性非随机临床试验(BDH 2008/02),纳入626例新诊断多发性骨髓瘤患者。
- 患者接受免疫调节药物或蛋白酶体抑制剂为基础的方案治疗。
- 收集缓解深度、达最佳缓解时间(TBR)和最佳缓解持续时间(DBR)。
主要发现
- 缓解深度与更优结局相关,与其他研究一致。
- 早期缓解者(TBR≤3个月)生存显著差于晚期缓解者。
- 快速完全缓解者生存不优于逐渐部分缓解者。
- 识别出4种不同缓解动力学模式。
- 缓慢持续缓解(「U型谷」模式)结局最优,快速短暂缓解(「过山车」模式)结局最差,中位总生存126 vs 30个月。
关键数值与推荐
- 早期缓解定义为TBR≤3个月。
- 「U型谷」模式中位总生存126个月,「过山车」模式30个月。
临床怎么用
- 评估多发性骨髓瘤预后时除缓解深度外应关注缓解动力学模式。
- 缓慢逐渐缓解提示有利预后,快速短暂缓解提示预后不良。
局限性
- 研究为非随机设计。
- 原文摘要未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rapid remission by induction therapy has long been recognized as an important predictor for long-time survival in acute leukemia. However, the impact of response kinetics on multiple myeloma (MM) seems to be different and remains unexplored. The relationship between response kinetics and outcome were assessed in 626 patients with newly diagnosed MM who were included in a prospective, nonrandomized clinical trial (BDH 2008/02). Patients were assigned to either immunomodulatory drug- or proteasome inhibitor-based therapy. The response depth, time to best response (TBR) and duration of best response (DBR) were collected. Depth of response was associated with superior outcomes, consistent with findings from other studies. However, the early responders (defined as TBR ≤3 months) showed significantly worse survival compared with late responders. We found that patients with rapid complete remission experienced inferior survivals comparable to those attaining a gradual partial remission. Moreover, 4 distinct response kinetics patterns were identified. Patients with gradual and sustained remission ("U-valley" pattern) experienced superior outcomes, whereas poor outcomes were observed in rapid and transient responders ("roller coaster" pattern) (median overall survival, 126 vs 30 months). The effects of response patterns on survival were confirmed in patients at different stages of disease and cytogenetic risk, including transplant-eligible patients and those attaining different extents of response depth. Collectively, our data indicated that slow and gradual response is a favorable prognostic factor in MM. In addition to response depth, the kinetic pattern of response is a simple and powerful predictor for survival even in the era of novel agents.
引用
- Yan Y, Mao X, Liu J, et al. The impact of response kinetics for multiple myeloma in the era of novel agents. Blood Adv. 2019. PMID: 31594763. doi:10.1182/bloodadvances.2019000432
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。